Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2013-01-29 Share Issue/Capital Cha…
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
Bio-Gate AG: Bio-Gate platziert Kapitalerhohung
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated January 29, 2013, titled "Bio-Gate AG: Bio-Gate platziert Kapitalerhöhung" (Bio-Gate AG: Bio-Gate places capital increase). The content explicitly details the successful completion of a capital increase, the inflow of over one million Euros, the placement price of new shares, and how the proceeds will be used for growth financing. This directly relates to fundraising, financing activities, and capital structure changes. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2013-01-29 German
Datum:22.01.2013
Annual Report Classification · 95% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for Bio-Gate AG for the fiscal year 2011. It contains a balance sheet (Bilanz), detailed notes (Anhang) covering accounting methods, equity, liabilities, and other financial disclosures. While it is not a full 10-K (which is a US-specific term), it functions as the comprehensive annual financial report for a German company. Given the provided categories, '10-K' is the standard classification for a full annual report containing financial statements, even for non-US entities. FY 2011
2013-01-22 German
Bio-Gate AG will Finanzkraft durch Kapitalerhohung verbessern
Share Issue/Capital Change Classification · 99% confidence The document is a corporate news release dated December 21, 2012, announcing a decision by the Management Board of Bio-Gate AG to increase capital ('Kapitalerhöhung') by issuing new shares for cash contributions ('Bareinlagen'). This action is explicitly described as a measure to improve the company's financial strength and finance growth. This directly corresponds to the definition of 'Capital/Financing Update'. The keywords 'Kapitalerhöhung', 'Kapitalmaßnahme', and 'neuen Aktien' strongly indicate this classification, matching the 'CAP' code.
2012-12-21 German
Bio-Gate AG setzt Kapitalmanahme um
Share Issue/Capital Change Classification · 99% confidence The document is a corporate news release dated November 22, 2012, titled "Bio-Gate AG setzt Kapitalmaßnahme um" (Bio-Gate AG implements capital measure). The text explicitly details a capital reduction (Herabsetzung des Grundkapitals) from 4.312 Mio. Euro to 1.078 Mio. Euro (a 4:1 reverse stock split) and mentions a subsequent planned capital increase with subscription rights. These actions directly relate to changes in the company's capital structure and financing activities. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). Although it is a short announcement, the core content is the execution of a financing event, not just the announcement of a report, making CAP more specific than RPA or RNS.
2012-11-22 German
Bio-Gate AG: Hauptversammlung beschliet Sanierungsmanahmen
Share Issue/Capital Change Classification · 99% confidence The document is a corporate news release dated October 25, 2012, announcing that the shareholders of Bio-Gate AG approved capital restructuring measures ('Sanierungsmaßnahmen') at an extraordinary general meeting ('außerordentlichen Hauptversammlung'). These measures include a capital reduction (4:1) followed by a rights issue. The key topic is a significant change in the company's capital structure resulting from a shareholder vote. This aligns directly with the definition of 'Capital/Financing Update' (CAP), as it details specific capital measures (reduction and increase). While it mentions the 'Hauptversammlung' (AGM/EGM), the core subject is the resulting capital action, not just the meeting logistics or voting results themselves. Therefore, CAP is the most precise fit.
2012-10-25 German
Bio-Gate verbessert Halbjahresergebnis
Earnings Release Classification · 100% confidence The document is titled 'Bio-Gate verbessert Halbjahresergebnis' (Bio-Gate improves half-year result) and contains detailed financial figures for the first six months of 2012 (H1 2012), including revenue, net loss, equity, and EPS. It explicitly discusses the 'Halbjahresergebnis' (half-year result). This content aligns perfectly with the definition of a comprehensive financial report for a period shorter than a year. Therefore, the classification should be Interim / Quarterly Report (IR). Although it mentions the full report is available online, the text provided is the substance of the interim financial disclosure, not just an announcement of its publication. H1 2012
2012-09-13 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.